Abstract

Targeting protein aggregation for the therapy of neurodegenerative diseases remains elusive for medicinal chemists, despite a number of small molecules known to interfere in amyloidogenesis, particularly of amyloid beta (A?) protein. Starting from previous findings in the antiaggregating activity of a class of indolin-2-ones inhibiting A? fibrillization, 5-methoxyisatin 3-(4-isopropylphenyl)hydrazone 1 was identified as a multitarget inhibitor of A? aggregation and cholinesterases with IC50s in the low ?M range. With the aim of increasing aqueous solubility, a Mannich-base functionalization led to the synthesis of N-methylpiperazine derivative 2. At acidic pH, an outstanding solubility increase of 2 over the parent compound 1 was proved through a turbidimetric method. HPLC analysis revealed an improved stability of the Mannich base 2 at pH2 along with a rapid release of1 in humanserum as wellas anoutstanding hydrolytic stability of the parent hydrazone. Coincubation of A?1-42 with 2resulted inthe accumulation oflow MW oligomers, asdetected with PICUPassay. Cell assays on SH-SY5Y cells revealed that 2 exerts strong cytoprotective effects in both cell viability and radical quenching assays, mainly related to its active metabolite 1. These findings show that 2 drives the formation of non-toxic, off-pathway A? oligomers unable to trigger the amyloid cascade and toxicity.

Autore Pugliese

• Giangregorio Nicola

Tutti gli autori

• Pisani L.; De Palma A.; Giangregorio N.; Miniero D.V.; Pesce P.; Nicolotti O.; Campagna F.; Altomare C.D.; Catto M.

Titolo volume/Rivista

European journal of pharmaceutical sciences

Anno di pubblicazione

2017

ISSN

0928-0987

ISBN

Non Disponibile

Numero di citazioni Wos

Nessuna citazione

Ultimo Aggiornamento Citazioni

Non Disponibile

Numero di citazioni Scopus

Non Disponibile

Ultimo Aggiornamento Citazioni

Non Disponibile

Settori ERC

Non Disponibile

Codici ASJC

Non Disponibile